- Home
- Publications
- Publication Search
- Publication Details
Title
The two faces of FBW7 in cancer drug resistance
Authors
Keywords
-
Journal
BIOESSAYS
Volume 33, Issue 11, Pages 851-859
Publisher
Wiley
Online
2011-09-01
DOI
10.1002/bies.201100101
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mcl-1 Ubiquitination and Destruction
- (2015) Hiroyuki Inuzuka et al. Oncotarget
- MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression
- (2011) Mikael Lerner et al. CELL CYCLE
- Drug transporters of platinum-based anticancer agents and their clinical significance
- (2011) Herman Burger et al. DRUG RESISTANCE UPDATES
- Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
- (2011) Alina Shapira et al. DRUG RESISTANCE UPDATES
- Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells
- (2011) Xiaohong Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation
- (2011) Roya Babaei-Jadidi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1
- (2011) S Huber et al. LEUKEMIA
- Nucleolar Targeting of the Fbw7 Ubiquitin Ligase by a Pseudosubstrate and Glycogen Synthase Kinase 3
- (2011) M. Welcker et al. MOLECULAR AND CELLULAR BIOLOGY
- SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
- (2011) Hiroyuki Inuzuka et al. NATURE
- Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
- (2011) Ingrid E. Wertz et al. NATURE
- A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL)
- (2011) Konstantinos J Mavrakis et al. NATURE GENETICS
- Gene silencing by microRNAs: contributions of translational repression and mRNA decay
- (2011) Eric Huntzinger et al. NATURE REVIEWS GENETICS
- Targeting the Phosphoinositide-3 (PI3) Kinase Pathway in Breast Cancer
- (2011) J. Baselga ONCOLOGIST
- Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer
- (2010) F Di Fiore et al. BRITISH JOURNAL OF CANCER
- The role of MAP kinases and MAP kinase phosphatase-1 in resistance to breast cancer treatment
- (2010) Kelly K. Haagenson et al. CANCER AND METASTASIS REVIEWS
- The Fbw7 Tumor Suppressor Targets KLF5 for Ubiquitin-Mediated Degradation and Suppresses Breast Cell Proliferation
- (2010) Dong Zhao et al. CANCER RESEARCH
- FoxM1 Mediates Resistance to Herceptin and Paclitaxel
- (2010) Janai R. Carr et al. CANCER RESEARCH
- Secondary mutations of BRCA1/2 and drug resistance
- (2010) Kiranjit K. Dhillon et al. CANCER SCIENCE
- Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers
- (2010) Ja-Lok Ku et al. CARCINOGENESIS
- Targeting the Mitogen-Activated Protein Kinase Pathway: Physiological Feedback and Drug Response
- (2010) C. A. Pratilas et al. CLINICAL CANCER RESEARCH
- PI(3)King Apart PTEN's Role in Cancer
- (2010) S. Zhang et al. CLINICAL CANCER RESEARCH
- Chemosensitization of Prostate Cancer by Modulating Bcl-2 Family Proteins
- (2010) David Karnak et al. CURRENT DRUG TARGETS
- Strategies for Overcoming Chemotherapy Resistance in Enterohepatic Tumours
- (2010) J.J.G. Marin et al. CURRENT MOLECULAR MEDICINE
- Notch Signaling Proteins: Legitimate Targets for Cancer Therapy
- (2010) Zhiwei Wang et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance
- (2010) Zhiwei Wang et al. DRUG RESISTANCE UPDATES
- Implication of microRNAs in drug resistance for designing novel cancer therapy
- (2010) Fazlul H. Sarkar et al. DRUG RESISTANCE UPDATES
- The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis
- (2010) Kuppusamy Balamurugan et al. EMBO JOURNAL
- Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib
- (2010) Thomas Yau et al. EXPERT OPINION ON PHARMACOTHERAPY
- Investigations of survivin: the past, present and future
- (2010) Chun Hei Antonio Cheung Frontiers in Bioscience-Landmark
- F-box and WD Repeat Domain-Containing 7 Regulates Intestinal Cell Lineage Commitment and Is a Haploinsufficient Tumor Suppressor
- (2010) Rocio Sancho et al. GASTROENTEROLOGY
- MicroRNA-223 Regulates Cyclin E Activity by Modulating Expression of F-box and WD-40 Domain Protein 7
- (2010) Yanfei Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia
- (2010) Dan-Dan Feng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- ABCG2: A potential marker of stem cells and novel target in stem cell and cancer therapy
- (2010) Xi-wei Ding et al. LIFE SCIENCES
- Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun
- (2010) Joerg D Hoeck et al. NATURE NEUROSCIENCE
- Weekly paclitaxel in the treatment of recurrent ovarian cancer
- (2010) Richard D. Baird et al. Nature Reviews Clinical Oncology
- Translating p53 into the clinic
- (2010) Chit Fang Cheok et al. Nature Reviews Clinical Oncology
- Ubiquitin-like protein conjugation and the ubiquitin–proteasome system as drug targets
- (2010) Lynn Bedford et al. NATURE REVIEWS DRUG DISCOVERY
- Pancreatic cancer: understanding and overcoming chemoresistance
- (2010) Zhiwei Wang et al. Nature Reviews Gastroenterology & Hepatology
- Presenilin modulates EGFR signaling and cell transformation by regulating the ubiquitin ligase Fbw7
- (2010) V Rocher-Ros et al. ONCOGENE
- Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor
- (2010) D Ercan et al. ONCOGENE
- The ubiquitous nature of cancer: the role of the SCFFbw7 complex in development and transformation
- (2010) K M Crusio et al. ONCOGENE
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- GSK3 regulates the expressions of human and mouse c-Myb via different mechanisms
- (2010) Kyoko Kitagawa et al. Cell Division
- p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases
- (2009) T. Yokobori et al. CANCER RESEARCH
- Perifosine Inhibits Mammalian Target of Rapamycin Signaling through Facilitating Degradation of Major Components in the mTOR Axis and Induces Autophagy
- (2009) L. Fu et al. CANCER RESEARCH
- Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
- (2009) Z. Wang et al. CANCER RESEARCH
- Forkhead box M1 transcription factor: A novel target for cancer therapy
- (2009) Zhiwei Wang et al. CANCER TREATMENT REVIEWS
- The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer
- (2009) Scott A. Kono et al. DRUG RESISTANCE UPDATES
- NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia
- (2009) P J Real et al. LEUKEMIA
- Resistance to Antiestrogen Arzoxifene Is Mediated by Overexpression of Cyclin D1
- (2009) Wilbert Zwart et al. MOLECULAR ENDOCRINOLOGY
- Targeting the ubiquitin system in cancer therapy
- (2009) Daniela Hoeller et al. NATURE
- Fbw7 promotes ubiquitin-dependent degradation of c-Myb: involvement of GSK3-mediated phosphorylation of Thr-572 in mouse c-Myb
- (2009) K Kitagawa et al. ONCOGENE
- Vincristine: Can its therapeutic index be enhanced?
- (2009) Andrew Moore et al. PEDIATRIC BLOOD & CANCER
- Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment
- (2008) Bing-Hua Jiang et al. DRUG RESISTANCE UPDATES
- Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL
- (2008) S. Matsuoka et al. GENES & DEVELOPMENT
- Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7
- (2008) Benjamin J. Thompson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy
- (2008) J A McCubrey et al. LEUKEMIA
- Is NF-κB a good target for cancer therapy? Hopes and pitfalls
- (2008) Véronique Baud et al. NATURE REVIEWS DRUG DISCOVERY
- Rational targeting of Notch signaling in cancer
- (2008) P Rizzo et al. ONCOGENE
- Fbw7 regulates the activity of endoreduplication mediators and the p53 pathway to prevent drug-induced polyploidy
- (2008) S Finkin et al. ONCOGENE
- It's T-ALL about Notch
- (2008) R M Demarest et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More